What is the appropriate treatment for Bowen's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Bowen's Disease

Curettage and cautery is the preferred first-line treatment for Bowen's disease, offering superior outcomes with shorter healing times (35 days vs 46 days), significantly less pain, fewer complications, and lower recurrence rates (9% vs 36%) compared to cryotherapy, particularly for lower leg lesions 1.

Treatment Algorithm

First-Line Surgical Options

For most lesions, especially on the lower legs:

  • Curettage and cautery under local anesthesia is the treatment of choice 1
    • Healing time: median 35 days
    • Recurrence rate: 9% at 2 years
    • Allows histological examination to rule out invasive disease
    • Critical advantage: Only surgical treatment can identify occult invasive squamous cell carcinoma that may be missed on initial biopsy 2

For head and neck lesions or cosmetically sensitive areas:

  • Mohs micrographic surgery provides excellent tissue preservation with only 6.3% recurrence at 5 years 3
    • Particularly important in the head/neck region (93.4% of cases in one series)
    • Allows margin control while preserving tissue

Second-Line Non-Surgical Options

When surgery is contraindicated or for multiple lesions:

Photodynamic therapy (PDT) with methyl aminolevulinate:

  • Recurrence-free survival: 88% at 1 year, 71% at 5 years 4
  • Best for lesions <300 mm² (<21 mm diameter)
  • Avoid in upper extremity lesions (higher recurrence risk)
  • Advantages: no scarring, can be repeated, preserves joint function 5
  • Critical caveat: 30% recurrence risk at 5 years requires prolonged follow-up 4

Topical therapies (imiquimod, diclofenac):

  • Consider for elderly patients with comorbidities 6
  • Useful when wound healing is compromised
  • Higher recurrence rates than surgical options

Avoid Cryotherapy

Cryotherapy is inferior to curettage and cautery 1:

  • Longer healing time (median 46 days, up to 90+ days for lower leg)
  • 10.4 times more likely to cause pain
  • Higher infection rates
  • Recurrence rate of 36% at 2 years
  • No tissue for histological confirmation of invasion

Critical Clinical Pitfalls

Misdiagnosis is common (46% incorrect initial diagnosis) 7:

  • Often confused with bowenoid papulosis, actinic keratosis, basal cell carcinoma
  • Always obtain biopsy confirmation - preferably punch biopsy over curette to assess full dermal thickness 8
  • 20% of cases initially misdiagnosed as other skin cancers 3

Risk of occult invasion:

  • 3-5% risk of progression to invasive squamous cell carcinoma 6
  • Biopsy may miss invasive areas that surgical excision would reveal 2
  • This is why surgical treatment with histological examination of the entire specimen is preferred

High-risk features requiring surgical excision:

  • Lesions >300 mm² (≥21 mm diameter) 4
  • Recurrent disease (50.7% of cases in one series) 3
  • Immunosuppressed patients 8

Patient-Specific Considerations

For elderly patients with multiple comorbidities (66% have comorbidities) 7:

  • Consider PDT or topical therapy if surgical risk is prohibitive
  • Common comorbidities include cardiovascular disease (39%), gastrointestinal disease (30%), respiratory disease (27%)

For lower leg lesions (most common site in some populations):

  • Curettage and cautery dramatically superior: 39 days healing vs 90 days with cryotherapy (P<0.001) 1

For multiple lesions:

  • PDT allows treatment of multiple sites simultaneously 5
  • Avoids multiple surgical procedures

The British Association of Dermatologists guideline 8 provides the framework for diagnosis and management, emphasizing histological confirmation and noting that treatment selection depends on lesion characteristics, though specific treatment recommendations require integration with the comparative effectiveness data from clinical studies.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.